ArticleFrontiers in plant science2026
Long-term methyl jasmonate exposure triggers COI1-independent induction of myrosinases
Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plants are constantly subjected to stresses such as herbivore attacks, which continuously activate the jasmonic acid (JA) signaling pathway in nature. However, knowledge about the effect of long-term activation of the JA signaling pathway on plant defense response remains limited. THIOGLUCOSIDE GLUCOHYDROLASE 1 (TGG1) and TGG2 are enzymes that activate defensive metabolites, namely glucosinolates, which are involved in defense against herbivores and pathogens. Here, we show that prolonged exposure to the wounding hormone methyl jasmonate (MeJA) enhances
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.